175 related articles for article (PubMed ID: 32316186)
1. Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab
Polikarpov DM; Campbell DH; McRobb LS; Wu J; Lund ME; Lu Y; Deyev SM; Davidson AS; Walsh BJ; Zvyagin AV; Gillatt DA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32316186
[TBL] [Abstract][Full Text] [Related]
2. Glypican-1 as a target for fluorescence molecular imaging of bladder cancer.
Polikarpov DM; Campbell DH; Zaslavsky AB; Lund ME; Wu A; Lu Y; Palapattu GS; Walsh BJ; Zvyagin AV; Gillatt DA
Int J Urol; 2021 Dec; 28(12):1290-1297. PubMed ID: 34498294
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Biodistribution of
Ghosh S; Fletcher NL; Huda P; Houston ZH; Howard CB; Lund ME; Lu Y; Campbell DH; Walsh BJ; Thurecht KJ
Mol Pharm; 2023 Mar; 20(3):1549-1563. PubMed ID: 36602058
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
[TBL] [Abstract][Full Text] [Related]
5. Targeted beta therapy of prostate cancer with
Yeh MC; Tse BWC; Fletcher NL; Houston ZH; Lund M; Volpert M; Stewart C; Sokolowski KA; Jeet V; Thurecht KJ; Campbell DH; Walsh BJ; Nelson CC; Russell PJ
EJNMMI Res; 2020 May; 10(1):46. PubMed ID: 32382920
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
8. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
9. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
[TBL] [Abstract][Full Text] [Related]
10. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38888861
[TBL] [Abstract][Full Text] [Related]
11. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model.
Liang M; Yang M; Wang F; Wang X; He B; Mei C; He J; Lin Y; Cao Q; Li D; Shan H
J Control Release; 2021 Apr; 332():171-183. PubMed ID: 33636245
[TBL] [Abstract][Full Text] [Related]
13. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
[TBL] [Abstract][Full Text] [Related]
16. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
17. Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma.
Privitera L; Waterhouse DJ; Preziosi A; Paraboschi I; Ogunlade O; Da Pieve C; Barisa M; Ogunbiyi O; Weitsman G; Hutchinson JC; Cross K; Biassoni L; Stoyanov D; Sebire N; Beard P; De Coppi P; Kramer-Marek G; Anderson J; Giuliani S
Cancer Res; 2023 Jun; 83(12):2077-2089. PubMed ID: 36934744
[TBL] [Abstract][Full Text] [Related]
18. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
[TBL] [Abstract][Full Text] [Related]
19. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
[TBL] [Abstract][Full Text] [Related]
20. Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates.
Sato K; Nagaya T; Nakamura Y; Harada T; Nani RR; Shaum JB; Gorka AP; Kim I; Paik CH; Choyke PL; Schnermann MJ; Kobayashi H
Mol Pharm; 2015 Sep; 12(9):3303-11. PubMed ID: 26261913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
